MALT1 Human siRNA Oligo Duplex (Locus ID 10892)

SKU SR307428

MALT1 (Human) - 3 unique 27mer siRNA duplexes - 2 nmol each

Product Data

• Purity: HPLC purified
• Quality Control: Tested by ESI-MS
• Sequences: Available with shipment
• Components:
  MALT1 (Human) - 3 unique 27mer siRNA duplexes - 2 nmol each (Locus ID 10892); Included - SR30004, Trilencer-27 Universal Scrambled Negative Control siRNA Duplex - 2 nmol; Included - SR30005, RNAse free siRNA Duplex Resuspension Buffer - 2 ml

  Once you identified the best-performing siRNA sequence of the kit, you can order a single siRNA individually.

  Cat#	SRXXXXXX followed by A, B or C, then add L; For example, for sequence A of SR300003, the SKU is SR300003AL.
  Description	10 nmol of siRNA of the above specified vial, scramble control NOT included
  Price	$/€ 375 per vial

  If you want to order 20 nmol, please order quantity of 2 units.; If you need negative control, please order SR30004 (2 nmol of scramble siRNA control)
  Need an individual siRNA?
• Stability: One year from date of shipment when stored at -20°C.
• Shipping: Ambient
• # of Transfections: Approximately 330 transfections/2nmol in 24-well plate under optimized conditions (final conc. 10 nM).
• Note: Single siRNA duplex (10nmol) can be ordered.

Reference Data

• RefSeq: NM_006785, NM_173844
• UniProt ID: Q9UDY8
• Synonyms: IMD12; MLT; MLT1; PCASP1
• Summary: This gene encodes a caspase-like protease that plays a role in BCL10-induced activation of NF-kappaB. The protein is a component of the CARMA1-BCL10-MALT1 (CBM) signalosome that triggers NF-kappaB signaling and lymphoctye activation following antigen-receptor stimulation. Mutations in this gene result in immunodeficiency 12 (IMD12). This gene has been found to be recurrently rearranged in chromosomal translocations with other genes in mucosa-associated lymphoid tissue lymphomas, including a t(11;18)(q21;q21) translocation with the baculoviral IAP repeat-containing protein 3 (also known as apoptosis inhibitor 2) locus [BIRC3(API2)-MALT1], and a t(14;18)(q32;q21) translocation with the immunoglobulin heavy chain locus (IGH-MALT1). Alternatively spliced transcript variants have been described for this gene. [provided by RefSeq, May 2018]
• Performance Guaranteed: OriGene guarantees that at least two of the three Dicer-Substrate duplexes in the kit will provide at least 70% or more knockdown of the target mRNA when used at 10 nM concentration by quantitative RT-PCR when the TYE-563 fluorescent transfection control duplex (cat# SR30002) indicates that >90% of the cells have been transfected and the HPRT positive control (cat# SR30003) provides 90% knockdown efficiency.; ; For non-conforming siRNA, requests for replacement product must be made within ninety (90) days from the date of delivery of the siRNA kit. To arrange for a free replacement with newly designed duplexes, please contact Technical Services at techsupport@origene.com. Please provide your data indicating the transfection efficiency and measurement of gene expression knockdown compared to the scrambled siRNA control (quantitative RT-PCR data required).